Press releases

Month Year

Email alerts

Mar 15, 2010

Medtronic Announces Initial Results of STOP AF Clinical Trial

Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation

MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...
Mar 14, 2010

Medtronic's Endeavor Stent Continues to Demonstrate Compelling and Consistent Long-Term Clinical Results

Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients

MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
Mar 12, 2010

Medtronic Starts International Study of CoreValve(R) Transcatheter Aortic Valve System

Post-Market Evaluation of Breakthrough Medical Device Begins Enrolling Patients; First Implants Occur in Germany

MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- Moving to expand the evidence base for the future of structural heart disease therapy,Medtronic, Inc. (NYSE: MDT), today announced the start of the...
Mar 12, 2010

FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy

MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
Mar 11, 2010

Medtronic Announces Public Offering of Senior Notes

MINNEAPOLIS, Mar 11, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.25 billion of its 3.0 percent Senior Notes due 2015, $1.25 billion of its 4.45...

Show per page